Future studies would be important to test this idea further including performing experiments to evaluate if alteration in the level or SUMO E3 ligase activity of TIF1γ affects the ability of SnoN to suppress TGFβ-induced EMT in bladder cancer cells [84]. The gene discussed is TGFB1; the disease is urinary bladder cancer.